Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | NPC1 | O15118 | 4/20 | 0.35 |
| ▸ | RAB9A | P51151 | 4/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5931306 | 0.81 | TGM2 (0.44) | EPHX2LMNA | |
| Methylamine SCHEMBL27678870 | 0.76 | TGM2 (0.42) | EPHX2LMNA | |
| SCHEMBL2472029 | 0.75 | EPHX2 (0.44) | EPHX2LMNAHTTKDM4E | |
| SCHEMBL26080176 | 0.74 | POLB (0.32) | RAB9ASMN1; SMN2 | |
| SCHEMBL513746 | 0.73 | EPHX2 (0.43) | EPHX2LMNANPC1HTTKDM4E | |
| SCHEMBL3675918 | 0.73 | EPHX2 (0.47) | EPHX2LMNAHTTKDM4E | |
| SCHEMBL3368297 | 0.70 | EPHX2 (0.41) | EPHX2LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9790159 | 0.70 | EPHX2 (0.41) | EPHX2LMNAHTT | |
| SCHEMBL28269863 | 0.69 | ADORA1 (0.47) | LMNAHTTHPGD | |
| SCHEMBL4251073 | 0.68 | LMNA (0.38) | EPHX2LMNANPC1SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7507818-B2 | Method for the production of alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2009-03-24 | — | — | US | disclosed |
| US-20060069254-A1 | Method for the production of alkoxycarbonylamino triazines | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069254-A1 | Method for the production of alkoxycarbonylamino triazines | ADH1C, ADH5, ADH1A | EPHX2 1165/4885LMNA 1887/4885NPC1 3027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.